61. 自己免疫性溶血性貧血 Autoimmune hemolytic anemia Clinical trials / Disease details

臨床試験数 : 146 / 薬物数 : 131 - (DrugBank : 59) / 標的遺伝子数 : 28 - 標的パスウェイ数 : 158

diseases per page:

Showing 1 to 10 of 146 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05757570 (ClinicalTrials.gov)	May 2023	24/2/2023	An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias	A Phase 1b Open-Label Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics o ...	Immune Thrombocytopenia;Idiopathic Thrombocytopenic Purpura;Warm Autoimmune Hemolytic Anemia;Cold Ag ...	Drug: povetacicept	Alpine Immune Sciences, Inc.	NULL	Not yet recruiting	18 Years	N/A	All	42	Phase 1	NULL
2	EUCTR2022-001773-31-ES (EUCTR)	14/02/2023	11/10/2022	A study of efficacy and safety of ianalumab in previously treated patients with warm autoimmune haem ...	A phase 3, randomized, double-blind, study to assess efficacy and safety of ianalumab (VAY736) versu ...	warm autoimmune haemolytic anaemia (wAIHA) MedDRA version: 25.0;Level: LLT;Classification code 10047 ...	Product Name: Ianalumab Product Code: VAY736 INN or Proposed INN: Ianalumab	Novartis Farmacéutica, S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	Argentina;Singapore;Hungary;United States;Japan;United Kingdom;Malaysia;Thailand;Spain;India;China;T ...
3	NCT05221619 (ClinicalTrials.gov)	January 31, 2023	5/1/2022	Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)	Nipocalimab Post-trial Access in Patients With Warm Autoimmune Hemolytic Anemia(wAIHA) Who Are Exper ...	Warm Autoimmune Hemolytic Anemia	Drug: Nipocalimab	Janssen Research & Development, LLC	NULL	Temporarily not available	N/A	N/A	All			NULL
4	NCT05676697 (ClinicalTrials.gov)	January 13, 2023	7/12/2022	PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic AnemiaPatients After Receiving Tw ...	Safety and Efficacy Study of PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anem ...	Autoimmune Hemolytic Anemia;Failure of Two Rounds of Treatment	Drug: Linperlisib	Institute of Hematology & Blood Diseases Hospital	YL-Pharma	Recruiting	18 Years	N/A	All	20	Phase 1	China
5	NCT05648968 (ClinicalTrials.gov)	December 30, 2022	23/11/2022	A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemo ...	A Phase 3, Randomized, Double-blind, Study to Assess Efficacy and Safety of Ianalumab (VAY736) Versu ...	Warm Autoimmune Hemolytic Anemia (wAIHA)	Biological: Ianalumab;Drug: Placebo	Novartis Pharmaceuticals	NULL	Recruiting	18 Years	N/A	All	90	Phase 3	Singapore
6	NCT05535933 (ClinicalTrials.gov)	September 2022	31/8/2022	HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia	A Randomized, Double-Blind, Placebo-Controlled Phase II/III Study to Evaluate the Efficacy, Safety, ...	Warm Antibody Autoimmune Hemolytic Anemia	Drug: HMPL-523(300mg PO QD);Drug: Placebo	Hutchison Medipharma Limited	NULL	Not yet recruiting	18 Years	75 Years	All	110	Phase 2/Phase 3	NULL
7	EUCTR2021-002844-66-DE (EUCTR)	30/05/2022	20/09/2021	Study of the Efficacy and Safety of Parsaclisib in Participants with Primary Warm Autoimmune Hemolyt ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Parsacli ...	Primary Warm Autoimmune Hemolytic Anemia MedDRA version: 20.0;Level: LLT;Classification code 1000382 ...	Product Name: Parsaclisib (1 mg) Product Code: INCB050465 INN or Proposed INN: Paraclisib Other descript ...	Incyte Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 3	United States;Japan;Ukraine;United Kingdom;Spain;Canada;Austria;Netherlands;Belgium;Poland;Italy;Isr ...
8	EUCTR2021-003160-27-HU (EUCTR)	19/04/2022	23/02/2022	A Randomized, Double-blind, Placebo-controlled Study to Evaluate Pegcetacoplan in Patients with Cold ...	A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy a ...	Patients with Cold Agglutinin Disease(CAD);Therapeutic area: Diseases [C] - Immune System Diseases [ ...	Trade Name: APL-2 Product Name: PEGCETACOPLAN (APL-2) Product Code: 2019171-69-6 INN or Proposed INN: Pe ...	Swedish Orphan Biovitrum AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	60	Phase 3	United States;Spain;Ukraine;Austria;Russian Federation;United Kingdom;Italy;France;Hungary;Canada;Bu ...
9	EUCTR2021-003160-27-ES (EUCTR)	04/04/2022	05/04/2022	A Randomized, Double-blind, Placebo-controlled Study to Evaluate Pegcetacoplan in Patients with Cold ...	A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy a ...	Patients with Cold Agglutinin Disease(CAD);Therapeutic area: Diseases [C] - Immune System Diseases [ ...	Trade Name: APL-2 Product Name: PEGCETACOPLAN (APL-2) Product Code: 2019171-69-6 INN or Proposed INN: Pe ...	Swedish Orphan Biovitrum AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	60	Phase 3	United States;Spain;Ukraine;Austria;Russian Federation;Italy;United Kingdom;France;Canada;Bulgaria;G ...
10	NCT05073458 (ClinicalTrials.gov)	March 15, 2022	28/9/2021	Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolyt ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Parsacli ...	Warm Autoimmune Hemolytic Anemia (wAIHA)	Drug: parsaclisinib;Drug: placebo	Incyte Corporation	NULL	Recruiting	18 Years	99 Years	All	100	Phase 3	United States;Austria;Belgium;Canada;France;Germany;Israel;Italy;Japan;Netherlands;Poland;Spain;Unit ...

First Previous1 2 3 4 5…15Next Last